These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28124228)

  • 1. The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome.
    Saponjski J; Stojanovich L; Petrovic J; Saponjski D
    Immunol Res; 2017 Apr; 65(2):482-486. PubMed ID: 28124228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal pain in patient with antiphospholipid syndrome-the role of MDCT angiography on visceral blood vessels.
    Saponjski J; Stojanovich L; Saponjski J; Mirilovic M; Saponjski D
    Immunol Res; 2017 Dec; 65(6):1150-1155. PubMed ID: 29134567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice?
    Saponjski J; Stojanovich L; Djokovic A; Petkovic M; Mrda D
    Autoimmun Rev; 2011 Feb; 10(4):235-7. PubMed ID: 21095242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].
    Chwalińska-Sadowska H; Meissner M; Wudarski M; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):401-6. PubMed ID: 17195351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
    Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome.
    Stojanovich L; Kontic M; Smiljanic D; Djokovic A; Stamenkovic B; Marisavljevic D
    Clin Exp Rheumatol; 2013; 31(5):756-60. PubMed ID: 23899875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The family history of patients with primary or secondary antiphospholipid syndrome (APS).
    Weber M; Hayem G; DeBandt M; Palazzo E; Roux S; Kahn MF; Meyer O
    Lupus; 2000; 9(4):258-63. PubMed ID: 10866096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?
    Weber M; Hayem G; De Bandt M; Seifert B; Palazzo E; Roux S; Kahn MF; Meyer O
    J Rheumatol; 1999 Oct; 26(10):2131-6. PubMed ID: 10529128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.
    Stojanovich L; Kontic M; Djokovic A; Ilijevski N; Stanisavljevic N; Marisavljevic D
    Scand J Rheumatol; 2012 May; 41(3):223-6. PubMed ID: 22324785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.
    Stanisavljevic N; Stojanovich L; Marisavljevic D; Djokovic A; Dopsaj V; Kotur-Stevuljevic J; Martinovic J; Memon L; Radovanovic S; Todic B; Lisulov D
    Clin Rheumatol; 2016 Oct; 35(10):2485-93. PubMed ID: 27562033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary Study on the Imbalance Between Th17 and Regulatory T Cells in Antiphospholipid Syndrome.
    Yan H; Li B; Su R; Gao C; Li X; Wang C
    Front Immunol; 2022; 13():873644. PubMed ID: 35603166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis.
    Foltyn Zadura A; Memon AA; Stojanovich L; Perricone C; Conti F; Valesini G; Bogdanovic G; Hillarp A; Shoenfeld Y; Sundquist J; Leffler J; Svensson PJ; Trouw LA; Blom AM
    J Rheumatol; 2015 Oct; 42(10):1786-93. PubMed ID: 26276971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
    Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
    Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory proteins in female and male patients with primary antiphospholipid syndrome: preliminary data.
    Bećarević M; Ignjatović S
    Clin Rheumatol; 2016 Oct; 35(10):2477-83. PubMed ID: 27370963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary antiphospholipid syndrome: absence of premature atherosclerosis in patients without traditional coronary artery disease risk factors.
    Andrade D; Bortolotto L; Bonfá E; Borba E
    Lupus; 2016 Apr; 25(5):472-8. PubMed ID: 26585072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for arterial thrombosis in antiphospholipid syndrome.
    Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
    Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signs of impaired immunoregulation and enhanced effector T-cell responses in the primary antiphospholipid syndrome.
    Jakiela B; Iwaniec T; Plutecka H; Celinska-Lowenhoff M; Dziedzina S; Musial J
    Lupus; 2016 Apr; 25(4):389-98. PubMed ID: 26657472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dyslipidemia in patients with antiphospholipid syndrome and its association with endothelial dysfunction and atherosclerotic changes in the carotid arteries].
    Shevchuk SV; Seheda IuS; Kuvikova IP
    Lik Sprava; 2013 Mar; (2):38-47. PubMed ID: 24605609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and immunological characteristics of primary and secondary antiphospholipid syndrome].
    Sulut'ian AE; Chapaeva NN; Shirinskiĭ VS; Kozhevnikov VS; Kozlov VA
    Klin Med (Mosk); 2004; 82(8):39-43. PubMed ID: 15468724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.